US to Drop Most COVID-19 Vaccine Mandates Next Week
The Biden Administration will lift most federal COVID-19 vaccine mandates next week, as the pandemic public health emergency ends on May 11.
Diagnosis & Disease Information
COVID-19 Vaccines Deemed Safe for Patients With Solid Tumors
Patients with solid tumors do not appear to have an increased risk of side effects from COVID-19 vaccination, according to a systematic review.
Patterns of COVID-19 Vaccination in Cancer Patients Who Already Had COVID-19
Several factors influenced the likelihood of COVID-19 vaccination among patients with cancer who already had COVID-19, a new study suggests.
Pfizer-BioNTech Bivalent Booster Authorized for Kids Under 5 Years
The FDA has authorized use of the bivalent Pfizer-BioNTech COVID-19 vaccine as a booster dose for children 6 months through 4 years of age.
Axillary Lymphadenopathy Resolves at Mean 102 Days After COVID-19 Booster
The mean time to resolution of axillary lymphadenopathy after a COVID-19 vaccine booster is 102 days, according to a study.
Preventing and Treating COVID-19 in Cancer Patients: Challenges in the Omicron Era
Methods to prevent and treat COVID-19 in cancer patients have had to evolve alongside the SARS-CoV-2 virus.
Many Patients With Hematologic Cancers Not Receiving COVID-19 Boosters
In patients with hematologic malignancies, uptake of COVID-19 vaccines is high for the first 2 doses but declines with each subsequent dose, a study suggests.
Moderna Will Not Be Charging for COVID-19 Vaccination After Public Health Emergency Ends
Vaccination with Moderna’s COVID-19 vaccines will remain free for US adults even after the COVID-19 public health emergency ends on May 11.
Bivalent COVID-19 Vaccine May Not Protect Cancer Patients From Current Variants
Pfizer-BioNTech’s bivalent COVID-19 vaccine may not protect cancer patients from the most common omicron subvariant in circulation now, a study suggests.
Vaccines Do Not Reduce the Risk of Severe COVID-19 Among Cancer Patients Receiving Certain Therapies
COVID-19 vaccines did not reduce the risk of severe COVID-19 among cancer patients who received radiation, CAR T-cell therapy, or HSCT.
- Loading...
Loading...
Next post in General Oncology
Loading... 
Loading...